By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Spero Therapeutics 

400 Technology Square, 10th Floor

Cambridge  Massachusetts  02139  U.S.A.
Phone: n/a Fax: n/a


Key Statistics

Ownership: Private

Web Site: Spero


Company News
Spero Announces $1.65 Million Award From Department Of Defense To Develop Novel Combination Therapy For Multidrug-Resistant, Gram-Negative Pathogens 10/18/2016 11:55:52 AM
Spero To Participate In Citi's 11th Annual Biotech Conference 9/6/2016 1:39:28 PM
Spero Joins ENABLE (European Gram-Negative Antibacterial Engine) Project To Combat Antibiotic-Resistant Bacteria 9/6/2016 9:49:18 AM
Spero To Present At The 2016 Wedbush Pacgrow Healthcare Conference 8/16/2016 11:23:09 AM
Spero Unveils Data On Lead Potentiator Candidate For The Treatment Of Multidrug Resistant Gram-Negative Infections At ASM Microbe 2016 6/21/2016 6:49:38 AM
Spero To Unveil Data On Potentiator Platform At ASM Microbe 2016 6/8/2016 10:43:55 AM
Spero Acquires Novel Gyrase Inhibitors From Vertex (VRTX) 5/25/2016 6:39:37 AM
Spero To Present At The 15th Annual Needham Healthcare Conference 4/5/2016 7:46:26 AM
Spero Hires Cristina Larkin As Chief Commercial Officer 3/2/2016 7:45:08 AM
Spero To Present At Cowen and Company 36th Annual Health Care Conference 2/29/2016 10:26:13 AM